Cart
sales@molnova.com
3-Deoxy-3-fluoroguanosine
CAS No. 123402-21-1
3-Deoxy-3-fluoroguanosine( —— )
Catalog No. M37878 CAS No. 123402-21-1
3'-Deoxy-3'-fluoroguanosine is a nucleoside phosphorylase inhibitor that inhibits RNA replication by binding replons. 3 '-Deoxy-3' -fluoroguanosine is used to treat viral hepatitis, cancer and other diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 34 | In Stock |
|
| 25MG | 65 | In Stock |
|
| 50MG | 90 | In Stock |
|
| 100MG | 124 | In Stock |
|
| 200MG | 183 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name3-Deoxy-3-fluoroguanosine
-
NoteResearch use only, not for human use.
-
Brief Description3'-Deoxy-3'-fluoroguanosine is a nucleoside phosphorylase inhibitor that inhibits RNA replication by binding replons. 3 '-Deoxy-3' -fluoroguanosine is used to treat viral hepatitis, cancer and other diseases.
-
Description3'-Deoxy-3'-fluoroguanosine is a nucleoside phosphorylase inhibitor that inhibits RNA replication by binding replons. 3 '-Deoxy-3' -fluoroguanosine is used to treat viral hepatitis, cancer and other diseases.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetAntibiotic
-
RecptorNucleoside Antimetabolite/Analog | DNA/RNA Synthesis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number123402-21-1
-
Formula Weight285.23
-
Molecular FormulaC10H12FN5O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@H](CO)[C@@H](F)[C@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
2-O-(2-Azidoethyl)ad...
2'-O-(2-azidoethyl)adenosine is a purine nucleoside analog with potential antitumor activity.
-
Phleomycin D1
Phleomycin D1 (PLM D1), a glycopeptide antibiotic in the Bleomycin/Phleomycin family, induces cell death by binding to and cleaving DNA .
-
REV 5901A
REV 5901A (REV 5901 HCl) is an orally active leukotriene receptor antagonist and 5-lipoxygenase inhibitor with antimicrobial activity that attenuates colon cancer growth in mice.
